Anatomic Pathology Peer-review Journals
Anatomical
Pathology is that branch of
drugs concerned with the study of the morphologic aspects of disease and includes subspecialties which will be oriented towards specific organ systems, (for example, gynecological pathology, dermatopathology, gastrointestinal pathology,
cardiovascular pathology, respiratory pathology,
musculoskeletal pathology, renal pathology, genito-urinary pathology, endocrine pathology, ophthalmic pathology, E.N.T. pathology, neuropathology), certain laboratory methods (for example, cytopathology, immunopathology, electron microscopy), or certain sorts of clinical cases (for example, pediatric pathology, forensic pathology). the highest
open access journals are peer reviewed scholarly
journals of Clinical & Experimental Pathology. the highest
open access journals are freely available on the general public internet domain, allowing any end users to read, download, copy, distribute, prink, search or link to the complete texts of the articles. These provide top quality , meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These
journals are indexed with all their citations noted. the highest
open access journals are indexed in MEDLINE, PUBMED, SCOPUS, COPERNICUS, CAS, EBSCO and ISI.Anatomic
pathology is that the study and diagnosis of the structural and functional alterations in cells,
tissues and organs that underlie disease. It forms the origin for much of the scientific reasoning and clinical decisions behind the practice of
drugs . It comprises of decedent pathology, surgical pathology, cytopathology, neuropathology and ophthalmic pathology. referee refers to the work done during the
screening of submitted manuscripts and funding applications.
High Impact List of Articles
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
When should the sequential parallel comparison design be used in clinical trials?
Lee Baer, Anastasia Ivanova
Clinical Trail Methodology: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
-
Results published on Phase II clinical trial for dengue vaccine
News and Views: Clinical Investigation
Relevant Topics in Clinical